top of page

PROFOUNDA, INC.

IMPAVIDO FOR ACANTHAMEOEBA KERATITIS

RHINASE NASAL GEL FOR DRYNESSNESS AND ALLERGIES

Profound Insights Lead to Better Products.

Check some of our Products!

CONTRACT MANUFACTURING

Click here to get in touch with the Profounda Team.

Toll Free: (407) 270-7790

Profounda takes on Leishmaniasis

Profounda takes on Leishmaniasis

Profounda licenses Impavido from Knight Therapeutics for marketing into the US. Leishmaniasis is a parasitic disease that is found in...

Knight Profounda U.S. Partner for Impavido

Knight Profounda U.S. Partner for Impavido

MONTREAL, Canada, September 25, 2015 – Knight Therapeutics Inc. (TSX: GUD) (“Knight”), through one of its wholly-owned subsidiaries,...

Featured Posts

Recent Posts

Here we come 2023!

Generic to Arestin Microspheres by Bausch Health (Orapharma) receives Competitive Generic Therapy De

DOG AND HUMANS GET GREAT RESULTS

Sales exceed $2 Million for first year of Profounda's Commercial Presence in the USA

Orphan drug status approval for Acanthamoeba Keratitis received by Profounda for Miltefosine

Profounda Inc. receives FDA orphan-drug designation for the Treatment of Primary Amebic Meningoencep

CNN report on Survivor of Brain Eating Amoeba

Patient survives Brain Eating Amoeba

Profounda working with local Health Officials in fight to save patients life.

Profounda Licensed in Florida

Archive

Search By Tags

No tags yet.

bottom of page